Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to evaluate the efficacy, tolerability, and safety of
quetiapine SR monotherapy and divalproex sodium ER monotherapy in comparison to placebo in
the treatment of ambulatory bipolar disorder with co-morbid lifetime panic disorder or
generalized anxiety disorder and current at least moderately severe anxiety.